Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia

NCT00049569 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

126

Enrollment

NIH

Sponsor class

Conditions

L1 Childhood Acute Lymphoblastic Leukemia
L2 Childhood Acute Lymphoblastic Leukemia
Non-T, Non-B Childhood Acute Lymphoblastic Leukemia
Recurrent Childhood Acute Lymphoblastic Leukemia
T-cell Childhood Acute Lymphoblastic Leukemia

Interventions

DRUG: cytarabine
DRUG: methotrexate
DRUG: vincristine sulfate
DRUG: prednisone
DRUG: pegaspargase
DRUG: doxorubicin hydrochloride
DRUG: imatinib mesylate
DRUG: cyclophosphamide
DRUG: etoposide
BIOLOGICAL: filgrastim
DRUG: leucovorin calcium
DRUG: asparaginase
DRUG: therapeutic hydrocortisone

Sponsor

National Cancer Institute (NCI)